Growth Metrics

EyePoint Pharmaceuticals (EYPT) Receivables: 2011-2018

Historic Receivables for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Jun 2018 value amounting to $353,000.

  • EyePoint Pharmaceuticals' Receivables rose 792.49% to $2.3 million in Q1 2019 from the same period last year, while for Mar 2019 it was $3.5 million, marking a year-over-year increase of 223.54%. This contributed to the annual value of $353,000 for FY2018, which is 40.64% up from last year.
  • Latest data reveals that EyePoint Pharmaceuticals reported Receivables of $353,000 as of FY2018, which was up 40.64% from $251,000 recorded in FY2017.
  • In the past 5 years, EyePoint Pharmaceuticals' Receivables ranged from a high of $622,000 in FY2015 and a low of $251,000 during FY2017.
  • In the last 3 years, EyePoint Pharmaceuticals' Receivables had a median value of $353,000 in 2018 and averaged $364,000.
  • Its Receivables has fluctuated over the past 5 years, first slumped by 48.57% in 2017, then spiked by 40.64% in 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Receivables (Yearly) stood at $517,000 in 2014, then climbed by 20.31% to $622,000 in 2015, then dropped by 21.54% to $488,000 in 2016, then crashed by 48.57% to $251,000 in 2017, then skyrocketed by 40.64% to $353,000 in 2018.